Overview
Atsushi Ono-Hirose practices in Hiroshima, Japan. Mr. Ono-Hirose is rated as an Experienced expert by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Liver Cancer, Hepatitis, Hepatitis C, Liver Transplant, and Endoscopy.
His clinical research consists of co-authoring 254 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Hemolytic Anemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- HepatitisMr. Ono-Hirose isDistinguished. Learn about Hepatitis.
- Liver CancerMr. Ono-Hirose isDistinguished. Learn about Liver Cancer.
- Advanced
- CirrhosisMr. Ono-Hirose isAdvanced. Learn about Cirrhosis.
- Hepatitis BMr. Ono-Hirose isAdvanced. Learn about Hepatitis B.
- Hepatitis CMr. Ono-Hirose isAdvanced. Learn about Hepatitis C.
- Experienced
- AnemiaMr. Ono-Hirose isExperienced. Learn about Anemia.
- Bile Duct StrictureMr. Ono-Hirose isExperienced. Learn about Bile Duct Stricture.
- Blood ClotsMr. Ono-Hirose isExperienced. Learn about Blood Clots.
- Contact DermatitisMr. Ono-Hirose isExperienced. Learn about Contact Dermatitis.
- D-Minus Hemolytic Uremic SyndromeMr. Ono-Hirose isExperienced. Learn about D-Minus Hemolytic Uremic Syndrome.
- D-Plus Hemolytic Uremic SyndromeMr. Ono-Hirose isExperienced. Learn about D-Plus Hemolytic Uremic Syndrome.